The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Ipsen; Sirtex Medical
Speakers' Bureau - Bayer; Sirtex Medical
Research Funding - Bayer; Ipsen
Pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC): KEYNOTE-224 update.
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Sanofi
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Richard S. Finn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Julien Edeline
Honoraria - BTG
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Stéphane Cattan
No Relationships to Disclose
 
Sadahisa Ogasawara
Honoraria - Bayer; Eisai
Consulting or Advisory Role - Bayer; Eisai
 
Daniel H. Palmer
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Research Funding - Bayer; Nucana
 
Chris Verslype
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Laetitia Fartoux
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Debashis Sarker
Honoraria - Bayer; Ipsen; Pfizer; Pfizer (I)
Consulting or Advisory Role - Baxalta; Blueprint Medicines; Eisai; Eisai (I); Ipsen (I); Novartis
Travel, Accommodations, Expenses - Bayer; ipsen; MiNA Therapeutics
 
Gontran Verset
No Relationships to Disclose
 
Stephen Lam Chan
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca/MedImmune; MSD Oncology; Novartis
Speakers' Bureau - Amgen; Bayer; Eisai
Research Funding - Novartis; Sirtex Medical
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca
 
Bruno Daniele
Honoraria - Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD
Consulting or Advisory Role - Bayer; Eisai
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen
 
Scot Ebbinghaus
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Junshui Ma
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Abby B. Siegel
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ann-Lii Cheng
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO
Speakers' Bureau - Novartis
Research Funding - Sanofi
 
Masatoshi Kudo
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Gilead Sciences; Merck Serono; Merck Serono; MSD; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)